“Risk Factors in Youth Tied to Early Dementia”

Mount Sinai Is First in the Nation to Perform Deep Brain Stimulation Implant as Part of Clinical Trial for Depression

Dysregulation of the Brain’s Reward Learning System Is Identified by Scientists as a Potential Driver and Treatment Target for Cocaine Addiction

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

Mount Sinai Health System to Lead Discussions on Women’s Health, New Paths to Treat and Prevent Brain Disease, and Closing the Health Disparity Gap at the 2023 Aspen Ideas: Health and Aspen Ideas Festival

Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children

Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans

Mount Sinai Launches Neurometabolomics and Neuroinformatics Core to Combat Rare Brain Diseases

Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain

Ian Maze, PhD, Named 2022 Recipient of Jacob P. Waletzky Award by Society for Neuroscience

Sites in the Brain Where RNA Is Edited Could Help to Better Understand Neurodevelopment and Disease, Researchers Have Found

Brain’s Sensitivity to Different Types of Regret May Impact Mood Disorders Like Depression, Mount Sinai Researchers Find